Analysis of Phase II Data for Celgene's Investigational Oral GED-0301 in Patients with Active Crohn's Disease Presented at Digestive Disease Week

Analysis of Phase II Data for Celgene's Investigational Oral GED-0301 in Patients with Active Crohn's Disease Presented at Digestive Disease Week